AbCellera Biologics Inc., a Canadian biotechnology startup that uses machine learning to develop antibody therapies, finds itself on the front lines of the Covid-19 global pandemic. The Vancouver-based company, which employs about 100 people, late last month received a sample from a patient who recovered from the novel coronavirus. AbCellera screened more than 5 million immune cells and used machine learning to identify those that produce the antibodies that helped that person neutralize the virus. That led to the identification…
Source: https://www.wsj.com/articles/biotech-company-uses-machine-learning-to-find-coronavirus-therapies-11584437401
